David G. Standaert, M.D., Ph.D. - Publications

Affiliations: 
Neurology University of Alabama, Birmingham, Birmingham, AL, United States 
Area:
Parkinson's disease

201 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Wallen ZD, Appah M, Dean MN, Sesler CL, Factor SA, Molho E, Zabetian CP, Standaert DG, Payami H. Characterizing dysbiosis of gut microbiome in PD: evidence for overabundance of opportunistic pathogens. Npj Parkinson's Disease. 6: 11. PMID 32566740 DOI: 10.1038/s41531-020-0112-6  0.84
2020 Lindestam Arlehamn CS, Dhanwani R, Pham J, Kuan R, Frazier A, Rezende Dutra J, Phillips E, Mallal S, Roederer M, Marder KS, Amara AW, Standaert DG, Goldman JG, Litvan I, Peters B, et al. α-Synuclein-specific T cell reactivity is associated with preclinical and early Parkinson's disease. Nature Communications. 11: 1875. PMID 32313102 DOI: 10.1038/s41467-020-15626-w  0.84
2020 Schonhoff AM, Williams GP, Wallen ZD, Standaert DG, Harms AS. Innate and adaptive immune responses in Parkinson's disease. Progress in Brain Research. 252: 169-216. PMID 32247364 DOI: 10.1016/bs.pbr.2019.10.006  1
2020 Espay AJ, Kalia LV, Gan-Or Z, Williams-Gray CH, Bedard PL, Rowe SM, Morgante F, Fasano A, Stecher B, Kauffman MA, Farrer MJ, Coffey CS, Schwarzschild MA, Sherer T, Postuma RB, ... ... Standaert DG, et al. Disease modification and biomarker development in Parkinson disease: Revision or reconstruction? Neurology. PMID 32102975 DOI: 10.1212/WNL.0000000000009107  1
2020 Williams GP, Marmion DJ, Schonhoff AM, Jurkuvenaite A, Won WJ, Standaert DG, Kordower JH, Harms AS. T cell infiltration in both human multiple system atrophy and a novel mouse model of the disease. Acta Neuropathologica. PMID 31993745 DOI: 10.1007/s00401-020-02126-w  1
2019 Stoyka LE, Arrant AE, Thrasher DR, Russell DL, Freire J, Mahoney CL, Narayanan A, Dib AG, Standaert DG, Volpicelli-Daley LA. Behavioral defects associated with amygdala and cortical dysfunction in mice with seeded α-synuclein inclusions. Neurobiology of Disease. 104708. PMID 31837424 DOI: 10.1016/j.nbd.2019.104708  1
2019 Eskow Jaunarajs KL, Scarduzio M, Ehrlich ME, McMahon LL, Standaert DG. Diverse mechanisms lead to common dysfunction of striatal cholinergic interneurons in distinct genetic mouse models of dystonia. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 31320448 DOI: 10.1523/JNEUROSCI.0407-19.2019  1
2019 Lindestam Arlehamn CS, Pham J, Alcalay RN, Frazier A, Shorr E, Carpenter C, Sidney J, Dhanwani R, Agin-Liebes J, Garretti F, Amara AW, Standaert DG, Phillips EJ, Mallal SA, Peters B, et al. Widespread Tau-Specific CD4 T Cell Reactivity in the General Population. Journal of Immunology (Baltimore, Md. : 1950). PMID 31085590 DOI: 10.4049/jimmunol.1801506  0.84
2019 Burack M, Aldred J, Zadikoff C, Vanagunas A, Klos K, Bilir B, Fernandez HH, Standaert DG. Reply to: DUOPA® is an Excellent Alternative Treatment but with Some Caveats. Movement Disorders Clinical Practice. 6: 336-337. PMID 31061847 DOI: 10.1002/mdc3.12738  1
2019 Espay AJ, Vizcarra JA, Marsili L, Lang AE, Simon DK, Merola A, Josephs KA, Fasano A, Morgante F, Savica R, Greenamyre JT, Cambi F, Yamasaki TR, Tanner CM, Gan-Or Z, ... ... Standaert DG, et al. Revisiting protein aggregation as pathogenic in sporadic Parkinson and Alzheimer diseases. Neurology. 92: 329-337. PMID 30745444 DOI: 10.1212/WNL.0000000000006926  1
2018 Burack M, Aldred J, Zadikoff C, Vanagunas A, Klos K, Bilir B, Fernandez HH, Standaert DG. Implementing Levodopa-Carbidopa Intestinal Gel for Parkinson Disease: Insights from US Practitioners. Movement Disorders Clinical Practice. 5: 383-393. PMID 30363427 DOI: 10.1002/mdc3.12630  1
2018 Williams GP, Schonhoff AM, Jurkuvenaite A, Thome AD, Standaert DG, Harms AS. Targeting of the class II transactivator attenuates inflammation and neurodegeneration in an alpha-synuclein model of Parkinson's disease. Journal of Neuroinflammation. 15: 244. PMID 30165873 DOI: 10.1186/s12974-018-1286-2  1
2018 Szaflarski JP, Bebin EM, Cutter G, DeWolfe J, Dure LS, Gaston TE, Kankirawatana P, Liu Y, Singh R, Standaert DG, Thomas AE, Ver Hoef LW. Cannabidiol improves frequency and severity of seizures and reduces adverse events in an open-label add-on prospective study. Epilepsy & Behavior : E&B. PMID 30100226 DOI: 10.1016/j.yebeh.2018.07.020  1
2018 Fernandez HH, Boyd JT, Fung VSC, Lew MF, Rodriguez RL, Slevin JT, Standaert DG, Zadikoff C, Vanagunas AD, Chatamra K, Eaton S, Facheris MF, Hall C, Robieson WZ, Benesh J, et al. Long-term safety and efficacy of levodopa-carbidopa intestinal gel in advanced Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 29570853 DOI: 10.1002/mds.27338  1
2018 Standaert DG, Boyd JT, Odin P, Robieson WZ, Zamudio J, Chatamra K. Systematic evaluation of levodopa-carbidopa intestinal gel patient-responder characteristics. Npj Parkinson's Disease. 4: 4. PMID 29387783 DOI: 10.1038/s41531-017-0040-2  1
2017 Standaert DG, Rodriguez RL, Slevin JT, Lobatz M, Eaton S, Chatamra K, Facheris MF, Hall C, Sail K, Jalundhwala YJ, Benesh J. Effect of Levodopa-carbidopa Intestinal Gel on Non-motor Symptoms in Patients with Advanced Parkinson's Disease. Movement Disorders Clinical Practice. 4: 829-837. PMID 29242809 DOI: 10.1002/mdc3.12526  1
2017 Harms AS, Thome AD, Yan Z, Schonhoff AM, Williams GP, Li X, Liu Y, Qin H, Benveniste EN, Standaert DG. Peripheral monocyte entry is required for alpha-Synuclein induced inflammation and Neurodegeneration in a model of Parkinson disease. Experimental Neurology. PMID 29155051 DOI: 10.1016/j.expneurol.2017.11.010  1
2017 Amara AW, Walker HC, Joop A, Cutter G, DeWolfe JL, Harding SM, Standaert DG. Effects of subthalamic nucleus deep brain stimulation on objective sleep outcomes in Parkinson's disease. Movement Disorders Clinical Practice. 4: 183-190. PMID 28924578 DOI: 10.1002/mdc3.12375  0.84
2017 Zimmerman CN, Eskow Jaunarajs KL, Meringolo M, Rizzo FR, Santoro M, Standaert DG, Pisani A. Evaluation of AZD1446 as a Therapeutic in DYT1 Dystonia. Frontiers in Systems Neuroscience. 11: 43. PMID 28659770 DOI: 10.3389/fnsys.2017.00043  1
2017 Scarduzio M, Zimmerman CN, Jaunarajs KL, Wang Q, Standaert DG, McMahon LL. Strength of cholinergic tone dictates the polarity of dopamine D2 receptor modulation of striatal cholinergic interneuron excitability in DYT1 dystonia. Experimental Neurology. PMID 28587876 DOI: 10.1016/j.expneurol.2017.06.005  1
2017 Figge D, Standaert DG. Dysregulation of BET proteins in levodopa-induced dyskinesia. Neurobiology of Disease. PMID 28286180 DOI: 10.1016/j.nbd.2017.03.003  1
2017 Espay AJ, Schwarzschild MA, Tanner CM, Fernandez HH, Simon DK, Leverenz JB, Merola A, Chen-Plotkin A, Brundin P, Kauffman MA, Erro R, Kieburtz K, Woo D, Macklin EA, Standaert DG, et al. Biomarker-driven phenotyping in Parkinson's disease: A translational missing link in disease-modifying clinical trials. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 28233927 DOI: 10.1002/mds.26913  1
2016 Birchall EL, Walker HC, Cutter G, Guthrie S, Joop A, Memon RA, Watts RL, Standaert DG, Amara AW. The effect of unilateral subthalamic nucleus deep brain stimulation on depression in Parkinson's disease. Brain Stimulation. PMID 28065487 DOI: 10.1016/j.brs.2016.12.014  0.84
2016 Zimmerman CN, Standaert DG. Cholinergic regulation of striatal dopamine release: New light in dark basements. Movement Disorders : Official Journal of the Movement Disorder Society. 31: 1796. PMID 27943474 DOI: 10.1002/mds.26846  1
2016 Apetauerova D, Scala SA, Hamill RW, Simon DK, Pathak S, Ruthazer R, Standaert DG, Yacoubian TA. CoQ10 in progressive supranuclear palsy: A randomized, placebo-controlled, double-blind trial. Neurology® Neuroimmunology & Neuroinflammation. 3: e266. PMID 27583276 DOI: 10.1212/NXI.0000000000000266  1
2016 Figge DA, Standaert DG. SNPing SCNA regulatory elements gives a CRISPR view of genetic susceptibility in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 27501414 DOI: 10.1002/mds.26747  1
2016 Figge DA, Eskow Jaunarajs KL, Standaert DG. Dynamic DNA Methylation Regulates Levodopa-Induced Dyskinesia. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 36: 6514-24. PMID 27307239 DOI: 10.1523/JNEUROSCI.0683-16.2016  1
2016 Fraser KB, Rawlins AB, Clark RG, Alcalay RN, Standaert DG, Liu N, West AB. Ser(P)-1292 LRRK2 in urinary exosomes is elevated in idiopathic Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 27297049 DOI: 10.1002/mds.26686  0.52
2016 Qin H, Buckley JA, Li X, Liu Y, Fox TH, Meares GP, Yu H, Yan Z, Harms AS, Li Y, Standaert DG, Benveniste EN. Inhibition of the JAK/STAT Pathway Protects Against α-Synuclein-Induced Neuroinflammation and Dopaminergic Neurodegeneration. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 36: 5144-59. PMID 27147665 DOI: 10.1523/JNEUROSCI.4658-15.2016  1
2016 Volpicelli-Daley LA, Kirik D, Stoyka LE, Standaert DG, Harms AS. How can rAAV-α-synuclein and the fibril α-synuclein models advance our understanding of Parkinson disease? Journal of Neurochemistry. PMID 27018978 DOI: 10.1111/jnc.13627  1
2016 Thome AD, Harms AS, Volpicelli-Daley LA, Standaert DG. microRNA-155 Regulates Alpha-Synuclein-Induced Inflammatory Responses in Models of Parkinson Disease. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 36: 2383-90. PMID 26911687 DOI: 10.1523/JNEUROSCI.3900-15.2016  1
2016 Ponnazhagan R, Harms AS, Thome AD, Jurkuvenaite A, Gogliotti R, Niswender CM, Conn PJ, Standaert DG. The Metabotropic Glutamate Receptor 4 Positive Allosteric Modulator ADX88178 Inhibits Inflammatory Responses in Primary Microglia. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology. PMID 26872456 DOI: 10.1007/s11481-016-9655-z  1
2016 Volpicelli-Daley LA, Standaert DG. Invisible Killers. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 26748962 DOI: 10.1002/mds.26465  1
2015 Thome AD, Standaert DG, Harms AS. Fractalkine Signaling Regulates the Inflammatory Response in an α-Synuclein Model of Parkinson Disease. Plos One. 10: e0140566. PMID 26469270 DOI: 10.1371/journal.pone.0140566  1
2015 Fernandez HH, Standaert DG, Chatamra K, Benesh JA. Reply to letter: Suicide in Parkinson's disease patients treated with levodopa-carbidopa Intestinal Gel. Movement Disorders : Official Journal of the Movement Disorder Society. 30: 1435-6. PMID 26179940 DOI: 10.1002/mds.26316  1
2015 Eskow Jaunarajs KL, Bonsi P, Chesselet MF, Standaert DG, Pisani A. Striatal cholinergic dysfunction as a unifying theme in the pathophysiology of dystonia. Progress in Neurobiology. 127: 91-107. PMID 25697043 DOI: 10.1016/j.pneurobio.2015.02.002  1
2015 Allen Reish HE, Standaert DG. Role of α-synuclein in inducing innate and adaptive immunity in Parkinson disease. Journal of Parkinson's Disease. 5: 1-19. PMID 25588354 DOI: 10.3233/JPD-140491  1
2015 Fernandez HH, Standaert DG, Hauser RA, Lang AE, Fung VS, Klostermann F, Lew MF, Odin P, Steiger M, Yakupov EZ, Chouinard S, Suchowersky O, Dubow J, Hall CM, Chatamra K, et al. Levodopa-carbidopa intestinal gel in advanced Parkinson's disease: final 12-month, open-label results. Movement Disorders : Official Journal of the Movement Disorder Society. 30: 500-9. PMID 25545465 DOI: 10.1002/mds.26123  1
2015 Skidmore FM, Spetsieris PG, Anthony T, Cutter GR, von Deneen KM, Liu Y, White KD, Heilman KM, Myers J, Standaert DG, Lahti AC, Eidelberg D, Ulug AM. A full-brain, bootstrapped analysis of diffusion tensor imaging robustly differentiates Parkinson disease from healthy controls. Neuroinformatics. 13: 7-18. PMID 24974315 DOI: 10.1007/s12021-014-9222-9  1
2014 Standaert DG, Olanow CW, Obeso JA. Scientific perspectives. Movement Disorders : Official Journal of the Movement Disorder Society. 29: 1230. PMID 25209257 DOI: 10.1002/mds.26015  1
2014 Lewis TB, Glasgow JN, Harms AS, Standaert DG, Curiel DT. Fiber-modified adenovirus for central nervous system Parkinson's disease gene therapy. Viruses. 6: 3293-310. PMID 25196484 DOI: 10.3390/v6083293  1
2014 Harms AS, Standaert DG. Monocytes and Parkinson's disease: invaders from outside? Movement Disorders : Official Journal of the Movement Disorder Society. 29: 1242. PMID 25124371 DOI: 10.1002/mds.25993  1
2014 West AB, Cowell RM, Daher JP, Moehle MS, Hinkle KM, Melrose HL, Standaert DG, Volpicelli-Daley LA. Differential LRRK2 expression in the cortex, striatum, and substantia nigra in transgenic and nontransgenic rodents. The Journal of Comparative Neurology. 522: 2465-80. PMID 24633735 DOI: 10.1002/cne.23583  1
2014 Kelly NA, Ford MP, Standaert DG, Watts RL, Bickel CS, Moellering DR, Tuggle SC, Williams JY, Lieb L, Windham ST, Bamman MM. Novel, high-intensity exercise prescription improves muscle mass, mitochondrial function, and physical capacity in individuals with Parkinson's disease. Journal of Applied Physiology (Bethesda, Md. : 1985). 116: 582-92. PMID 24408997 DOI: 10.1152/japplphysiol.01277.2013  1
2014 Yacoubian TA, Standaert DG. Reaping what you sow: Cross-seeding between aggregation-prone proteins in neurodegeneration. Movement Disorders : Official Journal of the Movement Disorder Society. 29: 306. PMID 24395732 DOI: 10.1002/mds.25766  1
2014 Olanow CW, Kieburtz K, Odin P, Espay AJ, Standaert DG, Fernandez HH, Vanagunas A, Othman AA, Widnell KL, Robieson WZ, Pritchett Y, Chatamra K, Benesh J, Lenz RA, Antonini A, et al. Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study. The Lancet. Neurology. 13: 141-9. PMID 24361112 DOI: 10.1016/S1474-4422(13)70293-X  1
2014 West AB, Gray M, Standaert DG. Basal Ganglia Disorders Reference Module in Biomedical Research. DOI: 10.1016/B978-0-12-801238-3.05589-6  1
2013 Amara AW, Standaert DG. Metabolomics and the search for biomarkers in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 28: 1620-1. PMID 24105981 DOI: 10.1002/mds.25644  1
2013 Eskow Jaunarajs KL, Standaert DG, Viegas TX, Bentley MD, Fang Z, Dizman B, Yoon K, Weimer R, Ravenscroft P, Johnston TH, Hill MP, Brotchie JM, Moreadith RW. Rotigotine polyoxazoline conjugate SER-214 provides robust and sustained antiparkinsonian benefit. Movement Disorders : Official Journal of the Movement Disorder Society. 28: 1675-82. PMID 24014074 DOI: 10.1002/mds.25625  1
2013 Fraser KB, Moehle MS, Daher JP, Webber PJ, Williams JY, Stewart CA, Yacoubian TA, Cowell RM, Dokland T, Ye T, Chen D, Siegal GP, Galemmo RA, Tsika E, Moore DJ, ... Standaert DG, et al. LRRK2 secretion in exosomes is regulated by 14-3-3. Human Molecular Genetics. 22: 4988-5000. PMID 23886663 DOI: 10.1093/hmg/ddt346  1
2013 Harms AS, Cao S, Rowse AL, Thome AD, Li X, Mangieri LR, Cron RQ, Shacka JJ, Raman C, Standaert DG. MHCII is required for α-synuclein-induced activation of microglia, CD4 T cell proliferation, and dopaminergic neurodegeneration. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 33: 9592-600. PMID 23739956 DOI: 10.1523/JNEUROSCI.5610-12.2013  1
2013 Eskow Jaunarajs KL, Standaert DG. Removing the blinkers: moving beyond striatal dopamine in Parkinson's disease. Journal of Neurochemistry. 125: 639-41. PMID 23682629 DOI: 10.1111/jnc.12167  1
2013 Steidinger TU, Slone SR, Ding H, Standaert DG, Yacoubian TA. Angiogenin in Parkinson disease models: role of Akt phosphorylation and evaluation of AAV-mediated angiogenin expression in MPTP treated mice. Plos One. 8: e56092. PMID 23409128 DOI: 10.1371/journal.pone.0056092  1
2013 Fernandez HH, Vanagunas A, Odin P, Espay AJ, Hauser RA, Standaert DG, Chatamra K, Benesh J, Pritchett Y, Hass SL, Lenz RA. Levodopa-carbidopa intestinal gel in advanced Parkinson's disease open-label study: interim results. Parkinsonism & Related Disorders. 19: 339-45. PMID 23287001 DOI: 10.1016/j.parkreldis.2012.11.020  1
2012 Cao S, Standaert DG, Harms AS. The gamma chain subunit of Fc receptors is required for alpha-synuclein-induced pro-inflammatory signaling in microglia. Journal of Neuroinflammation. 9: 259. PMID 23186369 DOI: 10.1186/1742-2094-9-259  1
2012 Li X, Lee J, Parsons D, Janaurajs K, Standaert DG. Evaluation of TorsinA as a target for Parkinson disease therapy in mouse models. Plos One. 7: e50063. PMID 23185535 DOI: 10.1371/journal.pone.0050063  1
2012 Saunders JA, Estes KA, Kosloski LM, Allen HE, Dempsey KM, Torres-Russotto DR, Meza JL, Santamaria PM, Bertoni JM, Murman DL, Ali HH, Standaert DG, Mosley RL, Gendelman HE. CD4+ regulatory and effector/memory T cell subsets profile motor dysfunction in Parkinson's disease. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology. 7: 927-38. PMID 23054369 DOI: 10.1007/s11481-012-9402-z  1
2012 Sciamanna G, Tassone A, Mandolesi G, Puglisi F, Ponterio G, Martella G, Madeo G, Bernardi G, Standaert DG, Bonsi P, Pisani A. Cholinergic dysfunction alters synaptic integration between thalamostriatal and corticostriatal inputs in DYT1 dystonia. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 32: 11991-2004. PMID 22933784 DOI: 10.1523/JNEUROSCI.0041-12.2012  1
2012 Sciamanna G, Hollis R, Ball C, Martella G, Tassone A, Marshall A, Parsons D, Li X, Yokoi F, Zhang L, Li Y, Pisani A, Standaert DG. Cholinergic dysregulation produced by selective inactivation of the dystonia-associated protein torsinA. Neurobiology of Disease. 47: 416-27. PMID 22579992 DOI: 10.1016/j.nbd.2012.04.015  1
2012 Zhang L, Yokoi F, Parsons DS, Standaert DG, Li Y. Alteration of striatal dopaminergic neurotransmission in a mouse model of DYT11 myoclonus-dystonia. Plos One. 7: e33669. PMID 22438980 DOI: 10.1371/journal.pone.0033669  1
2012 Moehle MS, Webber PJ, Tse T, Sukar N, Standaert DG, DeSilva TM, Cowell RM, West AB. LRRK2 inhibition attenuates microglial inflammatory responses. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 32: 1602-11. PMID 22302802 DOI: 10.1523/JNEUROSCI.5601-11.2012  1
2012 Amara AW, Standaert DG, Guthrie S, Cutter G, Watts RL, Walker HC. Unilateral subthalamic nucleus deep brain stimulation improves sleep quality in Parkinson's disease. Parkinsonism & Related Disorders. 18: 63-8. PMID 21924664 DOI: 10.1016/j.parkreldis.2011.09.001  1
2011 Yokoi F, Dang MT, Li J, Standaert DG, Li Y. Motor deficits and decreased striatal dopamine receptor 2 binding activity in the striatum-specific Dyt1 conditional knockout mice. Plos One. 6: e24539. PMID 21931745 DOI: 10.1371/journal.pone.0024539  1
2011 Sciamanna G, Tassone A, Martella G, Mandolesi G, Puglisi F, Cuomo D, Madeo G, Ponterio G, Standaert DG, Bonsi P, Pisani A. Developmental profile of the aberrant dopamine D2 receptor response in striatal cholinergic interneurons in DYT1 dystonia. Plos One. 6: e24261. PMID 21912682 DOI: 10.1371/journal.pone.0024261  1
2011 Zhang L, Yokoi F, Jin YH, DeAndrade MP, Hashimoto K, Standaert DG, Li Y. Altered dendritic morphology of Purkinje cells in Dyt1 ΔGAG knock-in and purkinje cell-specific Dyt1 conditional knockout mice. Plos One. 6: e18357. PMID 21479250 DOI: 10.1371/journal.pone.0018357  1
2011 Lewis TB, Standaert DG. Parkinson's disease, primates, and gene therapy: vive la différence? Movement Disorders : Official Journal of the Movement Disorder Society. 26: 2-3. PMID 21322013 DOI: 10.1002/mds.23544  1
2011 Standaert DG. Update on the pathology of dystonia. Neurobiology of Disease. 42: 148-51. PMID 21220015 DOI: 10.1016/j.nbd.2011.01.012  1
2011 Steidinger TU, Standaert DG, Yacoubian TA. A neuroprotective role for angiogenin in models of Parkinson's disease. Journal of Neurochemistry. 116: 334-41. PMID 21091473 DOI: 10.1111/j.1471-4159.2010.07112.x  1
2010 Yacoubian TA, Slone SR, Harrington AJ, Hamamichi S, Schieltz JM, Caldwell KA, Caldwell GA, Standaert DG. Differential neuroprotective effects of 14-3-3 proteins in models of Parkinson's disease. Cell Death & Disease. 1: e2. PMID 21152247 DOI: 10.1038/cddis.2009.4  1
2010 Cantuti-Castelvetri I, Hernandez LF, Keller-McGandy CE, Kett LR, Landy A, Hollingsworth ZR, Saka E, Crittenden JR, Nillni EA, Young AB, Standaert DG, Graybiel AM. Levodopa-induced dyskinesia is associated with increased thyrotropin releasing hormone in the dorsal striatum of hemi-parkinsonian rats. Plos One. 5: e13861. PMID 21085660 DOI: 10.1371/journal.pone.0013861  1
2010 Cao S, Theodore S, Standaert DG. Fcγ receptors are required for NF-κB signaling, microglial activation and dopaminergic neurodegeneration in an AAV-synuclein mouse model of Parkinson's disease. Molecular Neurodegeneration. 5: 42. PMID 20977765 DOI: 10.1186/1750-1326-5-42  1
2010 Lewis TB, Glasgow JN, Glandon AM, Curiel DT, Standaert DG. Transduction of brain dopamine neurons by adenoviral vectors is modulated by CAR expression: rationale for tropism modified vectors in PD gene therapy. Plos One. 5. PMID 20862245 DOI: 10.1371/journal.pone.0012672  1
2010 Standaert DG, Yacoubian TA. Target validation: the Parkinson disease perspective. Disease Models & Mechanisms. 3: 259-62. PMID 20427553 DOI: 10.1242/dmm.004192  1
2010 Napolitano F, Pasqualetti M, Usiello A, Santini E, Pacini G, Sciamanna G, Errico F, Tassone A, Di Dato V, Martella G, Cuomo D, Fisone G, Bernardi G, Mandolesi G, Mercuri NB, ... Standaert DG, et al. Dopamine D2 receptor dysfunction is rescued by adenosine A2A receptor antagonism in a model of DYT1 dystonia. Neurobiology of Disease. 38: 434-45. PMID 20227500 DOI: 10.1016/j.nbd.2010.03.003  1
2010 Ruan Q, Harrington AJ, Caldwell KA, Caldwell GA, Standaert DG. VPS41, a protein involved in lysosomal trafficking, is protective in Caenorhabditis elegans and mammalian cellular models of Parkinson's disease. Neurobiology of Disease. 37: 330-8. PMID 19850127 DOI: 10.1016/j.nbd.2009.10.011  1
2010 Breakefield XO, Standaert DG. Torsion Dystonia Encyclopedia of Neuroscience. 1029-1034. DOI: 10.1016/B978-008045046-9.01507-2  1
2009 Yacoubian TA, Howard G, Kissela B, Sands CD, Standaert DG. Racial differences in Parkinson's disease medication use in the reasons for geographic and racial differences in stroke cohort: a cross-sectional study. Neuroepidemiology. 33: 329-34. PMID 19887838 DOI: 10.1159/000254568  1
2009 Caldwell KA, Tucci ML, Armagost J, Hodges TW, Chen J, Memon SB, Blalock JE, DeLeon SM, Findlay RH, Ruan Q, Webber PJ, Standaert DG, Olson JB, Caldwell GA. Investigating bacterial sources of toxicity as an environmental contributor to dopaminergic neurodegeneration. Plos One. 4: e7227. PMID 19806188 DOI: 10.1371/journal.pone.0007227  1
2009 Martella G, Tassone A, Sciamanna G, Platania P, Cuomo D, Viscomi MT, Bonsi P, Cacci E, Biagioni S, Usiello A, Bernardi G, Sharma N, Standaert DG, Pisani A. Impairment of bidirectional synaptic plasticity in the striatum of a mouse model of DYT1 dystonia: role of endogenous acetylcholine. Brain : a Journal of Neurology. 132: 2336-49. PMID 19641103 DOI: 10.1093/brain/awp194  1
2009 Sciamanna G, Bonsi P, Tassone A, Cuomo D, Tscherter A, Viscomi MT, Martella G, Sharma N, Bernardi G, Standaert DG, Pisani A. Impaired striatal D2 receptor function leads to enhanced GABA transmission in a mouse model of DYT1 dystonia. Neurobiology of Disease. 34: 133-45. PMID 19187797 DOI: 10.1016/j.nbd.2009.01.001  1
2009 Crittenden JR, Cantuti-Castelvetri I, Saka E, Keller-McGandy CE, Hernandez LF, Kett LR, Young AB, Standaert DG, Graybiel AM. Dysregulation of CalDAG-GEFI and CalDAG-GEFII predicts the severity of motor side-effects induced by anti-parkinsonian therapy. Proceedings of the National Academy of Sciences of the United States of America. 106: 2892-6. PMID 19171906 DOI: 10.1073/pnas.0812822106  1
2009 Yacoubian TA, Standaert DG. Targets for neuroprotection in Parkinson's disease. Biochimica Et Biophysica Acta. 1792: 676-87. PMID 18930814 DOI: 10.1016/j.bbadis.2008.09.009  1
2008 Qiao L, Hamamichi S, Caldwell KA, Caldwell GA, Yacoubian TA, Wilson S, Xie ZL, Speake LD, Parks R, Crabtree D, Liang Q, Crimmins S, Schneider L, Uchiyama Y, Iwatsubo T, ... ... Standaert DG, et al. Lysosomal enzyme cathepsin D protects against alpha-synuclein aggregation and toxicity. Molecular Brain. 1: 17. PMID 19021916 DOI: 10.1186/1756-6606-1-17  1
2008 Theodore S, Cao S, McLean PJ, Standaert DG. Targeted overexpression of human alpha-synuclein triggers microglial activation and an adaptive immune response in a mouse model of Parkinson disease. Journal of Neuropathology and Experimental Neurology. 67: 1149-58. PMID 19018246 DOI: 10.1097/NEN.0b013e31818e5e99  1
2008 Hallett PJ, Collins TL, Standaert DG, Dunah AW. Biochemical fractionation of brain tissue for studies of receptor distribution and trafficking. Current Protocols in Neuroscience / Editorial Board, Jacqueline N. Crawley ... [Et Al.]. Unit 1.16. PMID 18428670 DOI: 10.1002/0471142301.ns0116s42  1
2008 Nicholas AP, Lubin FD, Hallett PJ, Vattem P, Ravenscroft P, Bezard E, Zhou S, Fox SH, Brotchie JM, Sweatt JD, Standaert DG. Striatal histone modifications in models of levodopa-induced dyskinesia. Journal of Neurochemistry. 106: 486-94. PMID 18410512 DOI: 10.1111/j.1471-4159.2008.05417.x  1
2008 Raju DV, Ahern TH, Shah DJ, Wright TM, Standaert DG, Hall RA, Smith Y. Differential synaptic plasticity of the corticostriatal and thalamostriatal systems in an MPTP-treated monkey model of parkinsonism. The European Journal of Neuroscience. 27: 1647-58. PMID 18380666 DOI: 10.1111/j.1460-9568.2008.06136.x  1
2008 Breakefield XO, Blood AJ, Li Y, Hallett M, Hanson PI, Standaert DG. The pathophysiological basis of dystonias. Nature Reviews. Neuroscience. 9: 222-34. PMID 18285800 DOI: 10.1038/nrn2337  1
2008 Yacoubian TA, Cantuti-Castelvetri I, Bouzou B, Asteris G, McLean PJ, Hyman BT, Standaert DG. Transcriptional dysregulation in a transgenic model of Parkinson disease. Neurobiology of Disease. 29: 515-28. PMID 18191405 DOI: 10.1016/j.nbd.2007.11.008  1
2008 Lewis TB, Standaert DG. Design of clinical trials of gene therapy in Parkinson disease. Experimental Neurology. 209: 41-7. PMID 17920590 DOI: 10.1016/j.expneurol.2007.08.012  1
2007 Grammatopoulos TN, Outeiro TF, Hyman BT, Standaert DG. Angiotensin II protects against alpha-synuclein toxicity and reduces protein aggregation in vitro. Biochemical and Biophysical Research Communications. 363: 846-51. PMID 17900533 DOI: 10.1016/j.bbrc.2007.09.043  1
2007 Balcioglu A, Kim MO, Sharma N, Cha JH, Breakefield XO, Standaert DG. Dopamine release is impaired in a mouse model of DYT1 dystonia. Journal of Neurochemistry. 102: 783-8. PMID 17550429 DOI: 10.1111/j.1471-4159.2007.04590.x  1
2007 Outeiro TF, Grammatopoulos TN, Altmann S, Amore A, Standaert DG, Hyman BT, Kazantsev AG. Pharmacological inhibition of PARP-1 reduces alpha-synuclein- and MPP+-induced cytotoxicity in Parkinson's disease in vitro models. Biochemical and Biophysical Research Communications. 357: 596-602. PMID 17449015 DOI: 10.1016/j.bbrc.2007.03.163  1
2007 Cantuti-Castelvetri I, Keller-McGandy C, Bouzou B, Asteris G, Clark TW, Frosch MP, Standaert DG. Effects of gender on nigral gene expression and parkinson disease. Neurobiology of Disease. 26: 606-14. PMID 17412603 DOI: 10.1016/j.nbd.2007.02.009  1
2007 St Martin JL, Klucken J, Outeiro TF, Nguyen P, Keller-McGandy C, Cantuti-Castelvetri I, Grammatopoulos TN, Standaert DG, Hyman BT, McLean PJ. Dopaminergic neuron loss and up-regulation of chaperone protein mRNA induced by targeted over-expression of alpha-synuclein in mouse substantia nigra. Journal of Neurochemistry. 100: 1449-57. PMID 17241127 DOI: 10.1111/j.1471-4159.2006.04310.x  1
2007 Scherzer CR, Eklund AC, Morse LJ, Liao Z, Locascio JJ, Fefer D, Schwarzschild MA, Schlossmacher MG, Hauser MA, Vance JM, Sudarsky LR, Standaert DG, Growdon JH, Jensen RV, Gullans SR. Molecular markers of early Parkinson's disease based on gene expression in blood. Proceedings of the National Academy of Sciences of the United States of America. 104: 955-60. PMID 17215369 DOI: 10.1073/pnas.0610204104  1
2007 Standaert DG, Cantuti-Castelvetri I. Sex Differences in Parkinson's Disease Sex Differences in the Brain: From Genes to Behavior. DOI: 10.1093/acprof:oso/9780195311587.003.0023  1
2006 Pisani A, Martella G, Tscherter A, Bonsi P, Sharma N, Bernardi G, Standaert DG. Altered responses to dopaminergic D2 receptor activation and N-type calcium currents in striatal cholinergic interneurons in a mouse model of DYT1 dystonia. Neurobiology of Disease. 24: 318-25. PMID 16934985 DOI: 10.1016/j.nbd.2006.07.006  1
2006 Sadri-Vakili G, Menon AS, Farrell LA, Keller-McGandy CE, Cantuti-Castelvetri I, Standaert DG, Augood SJ, Yohrling GJ, Cha JH. Huntingtin inclusions do not down-regulate specific genes in the R6/2 Huntington's disease mouse. The European Journal of Neuroscience. 23: 3171-5. PMID 16820007 DOI: 10.1111/j.1460-9568.2006.04871.x  1
2006 Ingelsson M, Ramasamy K, Cantuti-Castelvetri I, Skoglund L, Matsui T, Orne J, Kowa H, Raju S, Vanderburg CR, Augustinack JC, de Silva R, Lees AJ, Lannfelt L, Growdon JH, Frosch MP, ... Standaert DG, et al. No alteration in tau exon 10 alternative splicing in tangle-bearing neurons of the Alzheimer's disease brain. Acta Neuropathologica. 112: 439-49. PMID 16802167 DOI: 10.1007/s00401-006-0095-3  1
2006 Hallett PJ, Spoelgen R, Hyman BT, Standaert DG, Dunah AW. Dopamine D1 activation potentiates striatal NMDA receptors by tyrosine phosphorylation-dependent subunit trafficking. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 26: 4690-700. PMID 16641250 DOI: 10.1523/JNEUROSCI.0792-06.2006  1
2005 Cantuti-Castelvetri I, Klucken J, Ingelsson M, Ramasamy K, McLean PJ, Frosch MP, Hyman BT, Standaert DG. Alpha-synuclein and chaperones in dementia with Lewy bodies. Journal of Neuropathology and Experimental Neurology. 64: 1058-66. PMID 16319716 DOI: 10.1097/01.jnen.0000190063.90440.69  1
2005 Wills AM, Plante DT, Dukkipati SR, Corcoran CP, Standaert DG. Pacemaker-induced tachycardia caused by inappropriate response to parkinsonian tremor. Neurology. 65: 1676-7. PMID 16301511 DOI: 10.1212/01.wnl.0000184489.74795.b2  1
2005 Miller DW, Johnson JM, Solano SM, Hollingsworth ZR, Standaert DG, Young AB. Absence of alpha-synuclein mRNA expression in normal and multiple system atrophy oligodendroglia. Journal of Neural Transmission (Vienna, Austria : 1996). 112: 1613-24. PMID 16284907 DOI: 10.1007/s00702-005-0378-1  1
2005 Cantuti-Castelvetri I, Lin MT, Zheng K, Keller-McGandy CE, Betensky RA, Johns DR, Beal MF, Standaert DG, Simon DK. Somatic mitochondrial DNA mutations in single neurons and glia. Neurobiology of Aging. 26: 1343-55. PMID 16243605 DOI: 10.1016/j.neurobiolaging.2004.11.008  1
2005 Sharma N, Baxter MG, Petravicz J, Bragg DC, Schienda A, Standaert DG, Breakefield XO. Impaired motor learning in mice expressing torsinA with the DYT1 dystonia mutation. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 25: 5351-5. PMID 15930383 DOI: 10.1523/JNEUROSCI.0855-05.2005  1
2005 Hallett PJ, Dunah AW, Ravenscroft P, Zhou S, Bezard E, Crossman AR, Brotchie JM, Standaert DG. Alterations of striatal NMDA receptor subunits associated with the development of dyskinesia in the MPTP-lesioned primate model of Parkinson's disease. Neuropharmacology. 48: 503-16. PMID 15755478 DOI: 10.1016/j.neuropharm.2004.11.008  1
2005 Standaert DG. Applications of laser capture microdissection in the study of neurodegenerative disease. Archives of Neurology. 62: 203-5. PMID 15710848 DOI: 10.1001/archneur.62.2.203  1
2005 Zucker B, Luthi-Carter R, Kama JA, Dunah AW, Stern EA, Fox JH, Standaert DG, Young AB, Augood SJ. Transcriptional dysregulation in striatal projection- and interneurons in a mouse model of Huntington's disease: neuronal selectivity and potential neuroprotective role of HAP1. Human Molecular Genetics. 14: 179-89. PMID 15548548 DOI: 10.1093/hmg/ddi014  1
2005 Sherrill DM, Hughes R, Salles SS, Lie-Nemeth T, Akay M, Standaert DG, Bonato P. Advanced analysis of wearable sensor data to adjust medication intake in patients with parkinson's disease 2nd International Ieee Embs Conference On Neural Engineering. 2005: 202-205. DOI: 10.1109/CNE.2005.1419591  1
2005 Sharma N, Cristopher Bragg D, Petravicz J, Standaert DG, Breakefield XO. DYT1 transgenic mouse Movement Disorders. 287-292. DOI: 10.1016/B978-012088382-0/50024-4  1
2004 Bonato P, Sherrill DM, Standaert DG, Salles SS, Akay M. Data mining techniques to detect motor fluctuations in Parkinson's disease. Conference Proceedings : ... Annual International Conference of the Ieee Engineering in Medicine and Biology Society. Ieee Engineering in Medicine and Biology Society. Annual Conference. 7: 4766-9. PMID 17271375 DOI: 10.1109/IEMBS.2004.1404319  1
2004 Lee IO, Yukhananov R, Standaert DG, Crosby G. NMDA-R1 antisense oligodeoxynucleotides modify formalin-induced nociception and spinal c-Fos expression in rat spinal cord. Pharmacology, Biochemistry, and Behavior. 79: 183-8. PMID 15388298 DOI: 10.1016/j.pbb.2004.07.003  1
2004 Rajadhyaksha A, Husson I, Satpute SS, Küppenbender KD, Ren JQ, Guerriero RM, Standaert DG, Kosofsky BE. L-type Ca2+ channels mediate adaptation of extracellular signal-regulated kinase 1/2 phosphorylation in the ventral tegmental area after chronic amphetamine treatment. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 24: 7464-76. PMID 15329393 DOI: 10.1523/JNEUROSCI.0612-04.2004  1
2004 Hallett PJ, Standaert DG. Rationale for and use of NMDA receptor antagonists in Parkinson's disease. Pharmacology & Therapeutics. 102: 155-74. PMID 15163596 DOI: 10.1016/j.pharmthera.2004.04.001  1
2004 Bai L, Hof PR, Standaert DG, Xing Y, Nelson SE, Young AB, Magnusson KR. Changes in the expression of the NR2B subunit during aging in macaque monkeys. Neurobiology of Aging. 25: 201-8. PMID 14749138 DOI: 10.1016/S0197-4580(03)00091-5  1
2004 Dunah AW, Sirianni AC, Fienberg AA, Bastia E, Schwarzschild MA, Standaert DG. Dopamine D1-dependent trafficking of striatal N-methyl-D-aspartate glutamate receptors requires Fyn protein tyrosine kinase but not DARPP-32. Molecular Pharmacology. 65: 121-9. PMID 14722243 DOI: 10.1124/mol.65.1.121  1
2004 Augood SJ, Hollingsworth Z, Albers DS, Yang L, Leung J, Breakefield XO, Standaert DG. Dopamine transmission in DYT1 dystonia. Advances in Neurology. 94: 53-60. PMID 14509654  1
2004 Cantuti-Castelvetri I, Standaert DG. Neuroprotective strategies for Parkinson's disease Current Neuropharmacology. 2: 309-322. DOI: 10.2174/1570159043359585  1
2003 Luthi-Carter R, Apostol BL, Dunah AW, DeJohn MM, Farrell LA, Bates GP, Young AB, Standaert DG, Thompson LM, Cha JH. Complex alteration of NMDA receptors in transgenic Huntington's disease mouse brain: analysis of mRNA and protein expression, plasma membrane association, interacting proteins, and phosphorylation. Neurobiology of Disease. 14: 624-36. PMID 14678777 DOI: 10.1016/j.nbd.2003.08.024  1
2003 Standaert DG. Adenosine A2A receptor modulation of motor systems for symptomatic therapy in Parkinson's disease. Neurology. 61: S30-1. PMID 14663006  1
2003 Augood SJ, Keller-McGandy CE, Siriani A, Hewett J, Ramesh V, Sapp E, DiFiglia M, Breakefield XO, Standaert DG. Distribution and ultrastructural localization of torsinA immunoreactivity in the human brain. Brain Research. 986: 12-21. PMID 12965225 DOI: 10.1016/S0006-8993(03)03164-0  1
2003 Standaert DG. Wearable technology's applications in Parkinson's disease. Ieee Engineering in Medicine and Biology Magazine : the Quarterly Magazine of the Engineering in Medicine & Biology Society. 22: 25-6. PMID 12845815  1
2003 Meyers JR, MacDonald RB, Duggan A, Lenzi D, Standaert DG, Corwin JT, Corey DP. Lighting up the senses: FM1-43 loading of sensory cells through nonselective ion channels. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 23: 4054-65. PMID 12764092  1
2003 Dunah AW, Standaert DG. Subcellular segregation of distinct heteromeric NMDA glutamate receptors in the striatum. Journal of Neurochemistry. 85: 935-43. PMID 12716425  1
2003 Rostasy K, Augood SJ, Hewett JW, Leung JC, Sasaki H, Ozelius LJ, Ramesh V, Standaert DG, Breakefield XO, Hedreen JC. TorsinA protein and neuropathology in early onset generalized dystonia with GAG deletion. Neurobiology of Disease. 12: 11-24. PMID 12609485 DOI: 10.1016/S0969-9961(02)00010-4  1
2003 Binkley PF, Frontera W, Standaert DG, Stein J. Predicting the Potential of Wearable Technology Ieee Engineering in Medicine and Biology Magazine. 22: 23-27. DOI: 10.1109/MEMB.2003.1213623  1
2002 Bi WL, Keller-McGandy C, Standaert DG, Augood SJ. Identification of nitric oxide synthase neurons for laser capture microdissection and mRNA quantification. Biotechniques. 33: 1274-83. PMID 12503312  1
2002 Sharma N, Standaert DG. Inherited movement disorders. Neurologic Clinics. 20: 759-78, vii. PMID 12432829 DOI: 10.1016/S0733-8619(01)00014-7  1
2002 Orlando LR, Dunah AW, Standaert DG, Young AB. Tyrosine phosphorylation of the metabotropic glutamate receptor mGluR5 in striatal neurons. Neuropharmacology. 43: 161-73. PMID 12213270 DOI: 10.1016/S0028-3908(02)00113-2  1
2002 Augood SJ, Hollingsworth Z, Albers DS, Yang L, Leung JC, Muller B, Klein C, Breakefield XO, Standaert DG. Dopamine transmission in DYT1 dystonia: a biochemical and autoradiographical study. Neurology. 59: 445-8. PMID 12177384  1
2002 Ziefer P, Leung J, Razzano T, Shalish C, LeDoux MS, Lorden JF, Ozelius L, Breakefield XO, Standaert DG, Augood SJ. Molecular cloning and expression of rat torsinA in the normal and genetically dystonic (dt) rat. Brain Research. Molecular Brain Research. 101: 132-5. PMID 12007841 DOI: 10.1016/S0169-328X(02)00176-6  1
2002 Dunah AW, Jeong H, Griffin A, Kim YM, Standaert DG, Hersch SM, Mouradian MM, Young AB, Tanese N, Krainc D. Sp1 and TAFII130 transcriptional activity disrupted in early Huntington's disease. Science (New York, N.Y.). 296: 2238-43. PMID 11988536 DOI: 10.1126/science.1072613  1
2002 Cantuti-Castelvetri I, Keller-McGandy CE, Albers DS, Beal MF, Vonsattel JP, Standaert DG, Augood SJ. Expression and activity of antioxidants in the brain in progressive supranuclear palsy. Brain Research. 930: 170-81. PMID 11879807 DOI: 10.1016/S0006-8993(02)02244-8  1
2001 Friedman J, Standaert DG. Dystonia and its disorders. Neurologic Clinics. 19: 681-705, vii. PMID 11532649 DOI: 10.1016/S0733-8619(05)70040-2  1
2001 Bahn S, Augood SJ, Ryan M, Standaert DG, Starkey M, Emson PC. Gene expression profiling in the post-mortem human brain--no cause for dismay. Journal of Chemical Neuroanatomy. 22: 79-94. PMID 11470556 DOI: 10.1016/S0891-0618(01)00099-0  1
2001 Dunah AW, Standaert DG. Dopamine D1 receptor-dependent trafficking of striatal NMDA glutamate receptors to the postsynaptic membrane. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 21: 5546-58. PMID 11466426  1
2000 Dunah AW, Wyszynski M, Martin DM, Sheng M, Standaert DG. alpha-actinin-2 in rat striatum: localization and interaction with NMDA glutamate receptor subunits. Brain Research. Molecular Brain Research. 79: 77-87. PMID 10925145 DOI: 10.1016/S0169-328X(00)00102-9  1
2000 Augood SJ, Hollingsworth ZR, Standaert DG, Emson PC, Penney JB. Localization of dopaminergic markers in the human subthalamic nucleus. The Journal of Comparative Neurology. 421: 247-55. PMID 10813785 DOI: 10.1002/(SICI)1096-9861(20000529)421:2<247::AID-CNE9>3.0.CO;2-F  1
2000 Chen JF, Beilstein M, Xu YH, Turner TJ, Moratalla R, Standaert DG, Aloyo VJ, Fink JS, Schwarzschild MA. Selective attenuation of psychostimulant-induced behavioral responses in mice lacking A(2A) adenosine receptors. Neuroscience. 97: 195-204. PMID 10771351 DOI: 10.1016/S0306-4522(99)00604-1  1
2000 Küppenbender KD, Standaert DG, Feuerstein TJ, Penney JB, Young AB, Landwehrmeyer GB. Expression of NMDA receptor subunit mRNAs in neurochemically identified projection and interneurons in the human striatum. The Journal of Comparative Neurology. 419: 407-21. PMID 10742712 DOI: 10.1002/(SICI)1096-9861(20000417)419:4<407::AID-CNE1>3.0.CO;2-I  1
2000 Dunah AW, Wang Y, Yasuda RP, Kameyama K, Huganir RL, Wolfe BB, Standaert DG. Alterations in subunit expression, composition, and phosphorylation of striatal N-methyl-D-aspartate glutamate receptors in a rat 6-hydroxydopamine model of Parkinson's disease. Molecular Pharmacology. 57: 342-52. PMID 10648644  1
2000 Albers DS, Augood SJ, Park LC, Browne SE, Martin DM, Adamson J, Hutton M, Standaert DG, Vonsattel JP, Gibson GE, Beal MF. Frontal lobe dysfunction in progressive supranuclear palsy: evidence for oxidative stress and mitochondrial impairment. Journal of Neurochemistry. 74: 878-81. PMID 10646541 DOI: 10.1046/j.1471-4159.2000.740878.x  1
1999 Augood SJ, Martin DM, Ozelius LJ, Breakefield XO, Penney JB, Standaert DG. Distribution of the mRNAs encoding torsinA and torsinB in the normal adult human brain. Annals of Neurology. 46: 761-9. PMID 10553994 DOI: 10.1002/1531-8249(199911)46:5<761::AID-ANA12>3.0.CO;2-Z  1
1999 Kosinski CM, Risso Bradley S, Conn PJ, Levey AI, Landwehrmeyer GB, Penney JB, Young AB, Standaert DG. Localization of metabotropic glutamate receptor 7 mRNA and mGluR7a protein in the rat basal ganglia. The Journal of Comparative Neurology. 415: 266-84. PMID 10545164 DOI: 10.1002/(SICI)1096-9861(19991213)415:2<266::AID-CNE9>3.0.CO;2-7  1
1999 Küppenbender KD, Albers DS, Iadarola MJ, Landwehrmeyer GB, Standaert DG. Localization of alternatively spliced NMDAR1 glutamate receptor isoforms in rat striatal neurons. The Journal of Comparative Neurology. 415: 204-17. PMID 10545160 DOI: 10.1002/(SICI)1096-9861(19991213)415:2<204::AID-CNE5>3.0.CO;2-V  1
1999 Albers DS, Augood SJ, Martin DM, Standaert DG, Vonsattel JP, Beal MF. Evidence for oxidative stress in the subthalamic nucleus in progressive supranuclear palsy. Journal of Neurochemistry. 73: 881-4. PMID 10428088 DOI: 10.1046/j.1471-4159.1999.0730881.x  1
1999 Wyszynski M, Valtschanoff JG, Naisbitt S, Dunah AW, Kim E, Standaert DG, Weinberg R, Sheng M. Association of AMPA receptors with a subset of glutamate receptor-interacting protein in vivo. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 19: 6528-37. PMID 10414981  1
1999 Bradley SR, Standaert DG, Levey AI, Conn PJ. Distribution of group III mGluRs in rat basal ganglia with subtype-specific antibodies. Annals of the New York Academy of Sciences. 868: 531-4. PMID 10414330 DOI: 10.1111/j.1749-6632.1999.tb11322.x  1
1999 Bradley SR, Standaert DG, Rhodes KJ, Rees HD, Testa CM, Levey AI, Conn PJ. Immunohistochemical localization of subtype 4a metabotropic glutamate receptors in the rat and mouse basal ganglia. The Journal of Comparative Neurology. 407: 33-46. PMID 10213186 DOI: 10.1002/(SICI)1096-9861(19990428)407:1<33::AID-CNE3>3.0.CO;2-G  1
1999 Simon DK, Standaert DG. Neuroprotective therapies. The Medical Clinics of North America. 83: 509-23, viii. PMID 10093591 DOI: 10.1016/S0025-7125(05)70117-6  1
1999 Standaert DG. NMDA receptors and nitric oxide synthase. Molecular Psychiatry. 4: 13-4. PMID 10089001  1
1999 Albers DS, Weiss SW, Iadarola MJ, Standaert DG. Immunohistochemical localization of N-methyl-D-aspartate and alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptor subunits in the substantia nigra pars compacta of the rat. Neuroscience. 89: 209-20. PMID 10051230 DOI: 10.1016/S0306-4522(98)00328-5  1
1999 Standaert DG, Friberg IK, Landwehrmeyer GB, Young AB, Penney JB. Expression of NMDA glutamate receptor subunit mRNAs in neurochemically identified projection and interneurons in the striatum of the rat. Brain Research. Molecular Brain Research. 64: 11-23. PMID 9889300 DOI: 10.1016/S0169-328X(98)00293-9  1
1998 Daggett LP, Johnson EC, Varney MA, Lin FF, Hess SD, Deal CR, Jachec C, Lu CC, Kerner JA, Landwehrmeyer GB, Standaert DG, Young AB, Harpold MM, Veliçelebi G. The human N-methyl-D-aspartate receptor 2C subunit: genomic analysis, distribution in human brain, and functional expression. Journal of Neurochemistry. 71: 1953-68. PMID 9798920  1
1998 Kerner JA, Standaert DG, Penney JB, Young AB, Landwehrmeyer GB. Simultaneous isotopic and nonisotopic in situ hybridization histochemistry with cRNA probes. Brain Research. Brain Research Protocols. 3: 22-32. PMID 9767088 DOI: 10.1016/S1385-299X(98)00017-8  1
1998 Kosinski CM, Standaert DG, Testa CM, Penney JB, Young AB. Expression of metabotropic glutamate receptor 1 isoforms in the substantia nigra pars compacta of the rat. Neuroscience. 86: 783-98. PMID 9692717 DOI: 10.1016/S0306-4522(97)00654-4  1
1998 Augood SJ, Penney JB, Friberg IK, Breakefield XO, Young AB, Ozelius LJ, Standaert DG. Expression of the early-onset torsion dystonia gene (DYT1) in human brain. Annals of Neurology. 43: 669-73. PMID 9585364 DOI: 10.1002/ana.410430518  1
1998 Friberg IK, Young AB, Standaert DG. Differential localization of the mRNAs for the pertussis toxin insensitive G-protein alpha sub-units Gq, G11, and Gz in the rat brain, and regulation of their expression after striatal deafferentation. Brain Research. Molecular Brain Research. 54: 298-310. PMID 9555065 DOI: 10.1016/S0169-328X(97)00346-X  1
1998 Weiss SW, Albers DS, Iadarola MJ, Dawson TM, Dawson VL, Standaert DG. NMDAR1 glutamate receptor subunit isoforms in neostriatal, neocortical, and hippocampal nitric oxide synthase neurons. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 18: 1725-34. PMID 9464997  1
1998 Counihan TJ, Landwehrmeyer GB, Standaert DG, Kosinski CM, Scherzer CR, Daggett LP, Veliçelebi G, Young AB, Penney JB. Expression of N-methyl-D-aspartate receptor subunit mRNA in the human brain: mesencephalic dopaminergic neurons. The Journal of Comparative Neurology. 390: 91-101. PMID 9456178 DOI: 10.1002/(SICI)1096-9861(19980105)390:1<91::AID-CNE8>3.0.CO;2-L  1
1998 Scherzer CR, Landwehrmeyer GB, Kerner JA, Counihan TJ, Kosinski CM, Standaert DG, Daggett LP, Veliçelebi G, Penney JB, Young AB. Expression of N-methyl-D-aspartate receptor subunit mRNAs in the human brain: hippocampus and cortex. The Journal of Comparative Neurology. 390: 75-90. PMID 9456177 DOI: 10.1002/(SICI)1096-9861(19980105)390:1<75::AID-CNE7>3.0.CO;2-N  1
1998 Kosinski CM, Standaert DG, Counihan TJ, Scherzer CR, Kerner JA, Daggett LP, Veliçelebi G, Penney JB, Young AB, Landwehrmeyer GB. Expression of N-methyl-D-aspartate receptor subunit mRNAs in the human brain: striatum and globus pallidus. The Journal of Comparative Neurology. 390: 63-74. PMID 9456176 DOI: 10.1002/(SICI)1096-9861(19980105)390:1<63::AID-CNE6>3.0.CO;2-O  1
1998 Testa CM, Friberg IK, Weiss SW, Standaert DG. Immunohistochemical localization of metabotropic glutamate receptors mGluR1a and mGluR2/3 in the rat basal ganglia. The Journal of Comparative Neurology. 390: 5-19. PMID 9456172 DOI: 10.1002/(SICI)1096-9861(19980105)390:1<5::AID-CNE2>3.0.CO;2-6  1
1997 Orlando LR, Luthi-Carter R, Standaert DG, Coyle JT, Penney JB, Young AB. N-acetylaspartylglutamate (NAAG) protects against rat striatal quinolinic acid lesions in vivo. Neuroscience Letters. 236: 91-4. PMID 9404819 DOI: 10.1016/S0304-3940(97)00769-6  1
1997 Wüllner U, Standaert DG, Testa CM, Penney JB, Young AB. Differential expression of kainate receptors in the basal ganglia of the developing and adult rat brain. Brain Research. 768: 215-23. PMID 9369318 DOI: 10.1016/S0006-8993(97)00645-8  1
1997 Kerner JA, Standaert DG, Penney JB, Young AB, Landwehrmeyer GB. Expression of group one metabotropic glutamate receptor subunit mRNAs in neurochemically identified neurons in the rat neostriatum, neocortex, and hippocampus. Brain Research. Molecular Brain Research. 48: 259-69. PMID 9332723 DOI: 10.1016/S0169-328X(97)00102-2  1
1997 Scherzer CR, Landwehrmeyer GB, Kerner JA, Standaert DG, Hollingsworth ZR, Daggett LP, Veliçelebi G, Penney JB, Young AB. Cellular distribution of NMDA glutamate receptor subunit mRNAs in the human cerebellum. Neurobiology of Disease. 4: 35-46. PMID 9258910 DOI: 10.1006/nbdi.1997.0136  1
1997 Kosinski CM, Cha JH, Young AB, Persichetti F, MacDonald M, Gusella JF, Penney JB, Standaert DG. Huntingtin immunoreactivity in the rat neostriatum: differential accumulation in projection and interneurons. Experimental Neurology. 144: 239-47. PMID 9168825 DOI: 10.1006/exnr.1997.6441  1
1996 Standaert DG, Landwehrmeyer GB, Kerner JA, Penney JB, Young AB. Expression of NMDAR2D glutamate receptor subunit mRNA in neurochemically identified interneurons in the rat neostriatum, neocortex and hippocampus. Brain Research. Molecular Brain Research. 42: 89-102. PMID 8915584 DOI: 10.1016/S0169-328X(96)00117-9  1
1996 Rudolf GD, Cronin CA, Landwehrmeyer GB, Standaert DG, Penney JB, Young AB. Expression of N-methyl-D-aspartate glutamate receptor subunits in the prefrontal cortex of the rat. Neuroscience. 73: 417-27. PMID 8783259 DOI: 10.1016/0306-4522(96)00048-6  1
1996 Penney JB, Standaert DG, Testa CM, Landwehrmeyer GB, Young AB. Glutamate receptor genes in Parkinson's disease. Advances in Neurology. 69: 79-86. PMID 8615188  1
1996 Standaert DG, Testa CM, Rudolf GD, Hollingsworth ZR. Inhibition of N-methyl-D-aspartate glutamate receptor subunit expression by antisense oligonucleotides reveals their role in striatal motor regulation. The Journal of Pharmacology and Experimental Therapeutics. 276: 342-52. PMID 8558453  1
1995 Orlando LR, Standaert DG, Penney JB, Young AB. Metabotropic receptors in excitotoxicity: (S)-4-carboxy-3-hydroxyphenylglycine ((S)-4C3HPG) protects against rat striatal quinolinic acid lesions. Neuroscience Letters. 202: 109-12. PMID 8787843 DOI: 10.1016/0304-3940(95)12219-2  1
1995 Testa CM, Standaert DG, Landwehrmeyer GB, Penney JB, Young AB. Differential expression of mGluR5 metabotropic glutamate receptor mRNA by rat striatal neurons. The Journal of Comparative Neurology. 354: 241-52. PMID 7782501 DOI: 10.1002/cne.903540207  1
1995 Dure LS, Wiess S, Standaert DG, Rudolf G, Testa CM, Young AB. DNA fragmentation and immediate early gene expression in rat striatum following quinolinic acid administration. Experimental Neurology. 133: 207-14. PMID 7649226 DOI: 10.1006/exnr.1995.1023  1
1995 Landwehrmeyer GB, Standaert DG, Testa CM, Penney JB, Young AB. NMDA receptor subunit mRNA expression by projection neurons and interneurons in rat striatum. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 15: 5297-307. PMID 7623152  1
1994 Testa CM, Standaert DG, Young AB, Penney JB. Metabotropic glutamate receptor mRNA expression in the basal ganglia of the rat. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 14: 3005-18. PMID 8182455  1
1994 Fotuhi M, Standaert DG, Testa CM, Penney JB, Young AB. Differential expression of metabotropic glutamate receptors in the hippocampus and entorhinal cortex of the rat. Brain Research. Molecular Brain Research. 21: 283-92. PMID 8170352 DOI: 10.1016/0169-328X(94)90259-3  1
1994 Standaert DG, Testa CM, Young AB, Penney JB. Organization of N-methyl-D-aspartate glutamate receptor gene expression in the basal ganglia of the rat. The Journal of Comparative Neurology. 343: 1-16. PMID 8027428 DOI: 10.1002/cne.903430102  1
1994 Catania MV, Landwehrmeyer GB, Testa CM, Standaert DG, Penney JB, Young AB. Metabotropic glutamate receptors are differentially regulated during development. Neuroscience. 61: 481-95. PMID 7969925 DOI: 10.1016/0306-4522(94)90428-6  1
1994 Wüllner U, Standaert DG, Testa CM, Landwehrmeyer GB, Catania MV, Penney JB, Young AB. Glutamate receptor expression in rat striatum: effect of deafferentation. Brain Research. 647: 209-19. PMID 7922497 DOI: 10.1016/0006-8993(94)91320-X  1
1993 Standaert DG, Testa CM, Penney JB, Young AB. Alternatively spliced isoforms of the NMDAR1 glutamate receptor subunit: differential expression in the basal ganglia of the rat. Neuroscience Letters. 152: 161-4. PMID 8515871 DOI: 10.1016/0304-3940(93)90508-I  1
1993 Standaert DG, Stern MB. Update on the management of Parkinson's disease. The Medical Clinics of North America. 77: 169-83. PMID 8093493  1
1992 Standaert DG, Galetta SL, Hurst RW, Chawluk JB. Magnetic resonance angiography in the evaluation of dural carotid- cavernous fistulas Journal of Neuroimaging. 2: 208-211.  1
1991 Standaert DG, Galetta SL, Atlas SW. Meningovascular syphilis with a gumma of the midbrain. Journal of Clinical Neuro-Ophthalmology. 11: 139-43. PMID 1836794  1
1991 Standaert DG, Lee VM, Greenberg BD, Lowery DE, Trojanowski JQ. Molecular features of hypothalamic plaques in Alzheimer's disease. The American Journal of Pathology. 139: 681-91. PMID 1653521  1
1988 Standaert DG, Saper CB. Origin of the atriopeptin-like immunoreactive innervation of the paraventricular nucleus of the hypothalamus. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 8: 1940-50. PMID 2968443  1
1988 Standaert DG, Needleman P, Day ML, Weigand R, Krause JE. Expression of the gene for preproatriopeptin in the central nervous system of the rat. Brain Research. 464: 7-13. PMID 2460196 DOI: 10.1016/0169-328X(88)90012-5  1
1987 Standaert DG, Cechetto DF, Needleman P, Saper CB. Inhibition of the firing of vasopressin neurons by atriopeptin. Nature. 329: 151-3. PMID 2957595 DOI: 10.1038/329151a0  1
1987 Day ML, Schwartz D, Wiegand RC, Stockman PT, Brunnert SR, Tolunay HE, Currie MG, Standaert DG, Needleman P. Ventricular atriopeptin. Unmasking of messenger RNA and peptide synthesis by hypertrophy or dexamethasone. Hypertension. 9: 485-91. PMID 2952591  1
1986 Standaert DG, Watson SJ, Houghten RA, Saper CB. Opioid peptide immunoreactivity in spinal and trigeminal dorsal horn neurons projecting to the parabrachial nucleus in the rat. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 6: 1220-6. PMID 3012010  1
1986 Standaert DG, Needleman P, Saper CB. Organization of atriopeptin-like immunoreactive neurons in the central nervous system of the rat. The Journal of Comparative Neurology. 253: 315-41. PMID 2947936 DOI: 10.1002/cne.902530304  1
1986 Standaert DG, Saper CB, Rye DB, Wainer BH. Colocalization of atriopeptin-like immunoreactivity with choline acetyltransferase- and substance P-like immunoreactivity in the pedunculopontine and laterodorsal tegmental nuclei in the rat. Brain Research. 382: 163-8. PMID 2429724 DOI: 10.1016/0006-8993(86)90126-5  1
1985 Cechetto DF, Standaert DG, Saper CB. Spinal and trigeminal dorsal horn projections to the parabrachial nucleus in the rat. The Journal of Comparative Neurology. 240: 153-60. PMID 3840498 DOI: 10.1002/cne.902400205  1
1985 Needleman P, Adams SP, Cole BR, Currie MG, Geller DM, Michener ML, Saper CB, Schwartz D, Standaert DG. Atriopeptins as cardiac hormones. Hypertension. 7: 469-82. PMID 2989170  1
1985 Saper CB, Standaert DG, Currie MG, Schwartz D, Geller DM, Needleman P. Atriopeptin-immunoreactive neurons in the brain: presence in cardiovascular regulatory areas. Science (New York, N.Y.). 227: 1047-9. PMID 2858127 DOI: 10.1126/science.2858127  1
1985 Standaert DG, Saper CB, Needeleman P. Atriopeptin: potent hormone and potential neuromediator Trends in Neurosciences. 8: 509-511. DOI: 10.1016/0166-2236(85)90182-1  1
1985 Standaert DG, Saper CB, Cechetto DF. Atriopeptin immunoreactive neurons in cardiovascular regulatory areas of the brain in the rat Federation Proceedings. 44: No. 6679.  1
1984 Schwarz TL, Lee GM, Siwicki KK, Standaert DG, Kravitz EA. Proctolin in the lobster: the distribution, release, and chemical characterization of a likely neurohormone. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 4: 1300-11. PMID 6144736  0.96
1977 Wong SS, DiMicco JA, Standaert DG, Dretchen KL. Beneficial effect of fluorocarbon emulsion media on the function of neuromuscular preparations in vitro. The Journal of General Physiology. 69: 655-66. PMID 864433  1
Show low-probability matches.